Skip to contentT
Thermo Fisher Scientific Inc.
T
TMOThermo Fisher Scientific Inc. Q1 2017 · 10-Q
Revenue$4.77B$4.77B+10.9% vs Q1 2016 Net income—
EPS Diluted$1.40$1.40+38.6% vs Q1 2016 Gross Profit$2,193,000,000+12.0% Operating Income$620,000,000+19.7%
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Thermo Fisher Scientific Inc. · CIK 97745 · Engraved from SEC EDGAR
Operating Cash Flow$361,000,000+7.9% Free Cash Flowderived$268,000,000+22.0% Margins · derivedGross margin46.0%+0.4 pt vs Q1 2016
Operating margin13.0%+1.0 pt vs Q1 2016
ended Apr 1, 2017 · filed May 5, 2017 · 34 d after period end